Arnold Caplan

Dr. Arnold Caplan is a Professor of Biology and Director of the Skeletal Research Center at Case Western Reserve University. He received his Ph.D. from The Johns Hopkins University School of Medicine. Dr. Caplan is a national and international scholar focusing on experimentation in the area of musculoskeletal and skin development. He has published over 400 papers and manuscripts and has long been supported by the NIH and other non-profit and for-profit agencies for his efforts in trying to understand the development, maturation, and aging of cartilage, bone, skin, and other mesenchymal tissues and for his pioneering research on Mesenchymal Stem Cells. Arnold Caplan is also the founder of Osiris Therapeutics, the first company to ever treat a patient with an autologous cell therapy product and to successfully bring the world’s first approved stem cell drug to market in Canada and New Zealand, remestemcel-L for treatment of GvHD (BLA currently under review by FDA).